8583 Results
1

WLWT: Early flu vaccine availability has some wondering if it's too soon for a flu shot

August 26, 2020

Jennifer Forrester, MD, associate professor of infectious diseases in the UC College of Medicine and UC Health physician, told WLWT that she appreciates the attention flu vaccines are suddenly getting from area residents. “There is nothing particularly wrong or harmful in getting the flu vaccine now versus waiting,” Forrester told WLWT.

5

Medpage Today: Offer STI screening to every adolescent who visits the ED

November 4, 2020

A University of Cincinnati researcher is recommending pediatric hospital emergency room consider screening for sexually transmitted infections, teenage and young patients who visit for other acute care issues. Findings by Dr. Mark Eckman, professor and director of the UC Division of General Internal Medicine, appear in the Journal of American Medical Association Pediatrics.

6

Medscape: Analysis boosts Fluvoxamine for COVID, but what's the evidence?

April 14, 2022

A report published recently in JAMA Open Network finds there's a strong likelihood that the antidepressant fluvoxamine (Luvox) may moderately lower rates of hospitalization due to COVID-19 in unvaccinated patients. However, outside experts cited by Medscape differ over whether the evidence from just three studies is strong enough to warrant adding the drug to the COVID-19 armamentarium. One of those experts sources is Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.

7

Local 12: COVID-19 antiviral pill in the works

September 29, 2021

Several companies, including Pfizer are developing a pill to fight COVID-19 symptoms. Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was interviewed by WKRC-TV, Local12 for a story about the antiviral medications and explained how they work.

9

Medscape: Merck's new COVID pill: 'Game-changer' or just one more tool?

October 11, 2021

Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was one of the sources cited in an article in Medscape on pharmaceutical company Merck developing a new pill for COVID-19. Fichtenbaum said it wasn't a 'home run' but it was encouraging.